4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline

C57H38N6 — CID 163848012

IUPAC4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline
SMILESc1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccc(-c5ccc(N(c6ccccc6)c6ccccc6)cc5)cc4c4cc5c(cc43)c3ccccc3n5-c3ccccc3)n2)cc1
InChIInChI=1S/C57H38N6/c1-6-18-40(19-7-1)55-58-56(41-20-8-2-9-21-41)60-57(59-55)63-52-35-32-42(39-30-33-46(34-31-39)61(43-22-10-3-11-23-43)44-24-12-4-13-25-44)36-48(52)50-38-53-49(37-54(50)63)47-28-16-17-29-51(47)62(53)45-26-14-5-15-27-45/h1-38H
InChIKeyORWPRXVKRQUSPZ-UHFFFAOYSA-N
MW806.97 g/mol
LogP14.54
Rot. Bonds8

About 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline

4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline (PubChem CID 163848012) has the molecular formula C57H38N6 and a molecular weight of 806.97 g/mol. Its IUPAC name is 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline.

Molecular Properties

Compound Name4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline
PubChem CID163848012
Molecular FormulaC57H38N6
Molecular Weight806.97 g/mol
Exact Mass806.32
IUPAC Name4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline
SMILESc1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccc(-c5ccc(N(c6ccccc6)c6ccccc6)cc5)cc4c4cc5c(cc43)c3ccccc3n5-c3ccccc3)n2)cc1
InChIInChI=1S/C57H38N6/c1-6-18-40(19-7-1)55-58-56(41-20-8-2-9-21-41)60-57(59-55)63-52-35-32-42(39-30-33-46(34-31-39)61(43-22-10-3-11-23-43)44-24-12-4-13-25-44)36-48(52)50-38-53-49(37-54(50)63)47-28-16-17-29-51(47)62(53)45-26-14-5-15-27-45/h1-38H
InChIKeyORWPRXVKRQUSPZ-UHFFFAOYSA-N
XLogP14.54
TPSA51.77 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms63
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500806.97
LogP ≤ 514.54
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline?
The IUPAC name of 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline (CID 163848012) is 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline.
What is the SMILES notation for 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline?
The canonical SMILES for 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline is c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccc(-c5ccc(N(c6ccccc6)c6ccccc6)cc5)cc4c4cc5c(cc43)c3ccccc3n5-c3ccccc3)n2)cc1.
What is the InChIKey of 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline?
The InChIKey is ORWPRXVKRQUSPZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C57H38N6/c1-6-18-40(19-7-1)55-58-56(41-20-8-2-9-21-41)60-57(59-55)63-52-35-32-42(39-30-33-46(34-31-39)61(43-22-10-3-11-23-43)44-24-12-4-13-25-44)36-48(52)50-38-53-49(37-54(50)63)47-28-16-17-29-51(47)62(53)45-26-14-5-15-27-45/h1-38H.
What are the key properties of 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline?
4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline has a molecular weight of 806.97 g/mol, XLogP of 14.54, 8 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-11-phenylindolo[3,2-b]carbazol-2-yl]-N,N-diphenylaniline is sourced from PubChem (CID 163848012), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).